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The Tyrosine-Containing Cytoplasmic Tail
of CD1b Is Essential for Its Efficient
Presentation of Bacterial Lipid Antigens
have been shown to be required for the specific re-
sponses of subpopulations of TCR (T cell receptor) ab1
CD42CD82 T cells or CD42CD81 T cells that recognize
pathogenic mycobacteria, including Mycobacterium tu-
berculosis and Mycobacterium leprae (Beckman et al.,
Robin M. Jackman,* Steffen Stenger,² Agnes Lee,*
D. Branch Moody,* Rick A. Rogers,§ Kayvan R. Niazi,²
Masahiko Sugita,* Robert L. Modlin,²³
Peter J. Peters,‖ and Steven A. Porcelli*#
*Lymphocyte Biology Section
1994, 1996; Rosat and Brenner, submitted). A fourthDivision of Rheumatology, Immunology, and Allergy
human CD1 protein, CD1d, has also recently beenBrigham and Women's Hospital
shown to be involved in activation of a specific subsetHarvard Medical School
of T cells (Exley et al., 1997). Remarkably, the antigensBoston, Massachusetts 02115
recognized by human CD1b- or CD1c-restricted T cells²Department of Microbiology and Immunology
are mycobacterial lipids and glycolipids (Beckman et³Division of Dermatology
al., 1994; Sieling et al., 1995; Moody et al., 1997). In mice,University of California at Los Angeles School
CD1d can also apparently present glycolipid antigensof Medicine
(Kawano et al., 1997). These findings, together with re-Los Angeles, California 90095
cent x-ray crystallographic data showing a deep hy-§BioMedical Imaging Institute
drophobic ligand binding groove in CD1 (Zeng et al.,Harvard School of Public Health
1997), have led to the hypothesis that CD1 proteins bindBoston, Massachusetts 02115
lipid antigens and display them in a manner that allows‖Department of Cell Biology
specific recognition by T cells (Moody et al., 1997).Utrecht University School of Medicine
Recent studies on the intracellular localization ofHeidelberglaan 100
CD1b show that this protein is prominently found in the3584 CX Utrecht
endocytic system of monocytes treated with cytokinesThe Netherlands
to induce a dendritic cell phenotype (Sugita et al., 1996;
Prigozy et al., 1997). CD1b isbroadly distributed in endo-
somal and lysosomal compartments, including those inSummary
which antigen loading for MHC class II molecules (MHC
class II compartments [MIICs]) is believed to occur.CD1b is anantigen-presenting molecule thatmediates
Studies of HeLa cells transfected with a truncated formrecognition of bacterial lipid and glycolipid antigens
of CD1b indicate that the endosomal localization ofby specific T cells. We demonstrate that the nine±
CD1b is dependent on signals contained in its cyto-
amino acid cytoplasmic tail of CD1b contains all of
plasmic tail (Sugita et al., 1996). This nine±amino acid
the signals required for its normal endosomal tar-
domain contains a tetrapeptide that conforms to a tyro-
geting, and that the single cytoplasmic tyrosine is a
sine-based signal denoted as YXXé (where Y is tyrosine,
critical component of the targeting motif. Mutant X represents any amino acid, and é is a bulky hydropho-
forms of CD1b lacking the endosomal targeting motif bic amino acid; (Sandoval and Bakke, 1994; Boll et al.,
are expressed at high levels on the cell surface but 1996; Marks et al., 1997). In a variety of other proteins,
are unable to efficiently present lipid antigens acquired tyrosine-based signals of this general type have been
either exogenously or from live intracellular organ- shown to direct intracellular targeting by binding to
isms. These results define the functional role of the adapter protein complexes that are believed to regulate
CD1b targeting motif in a physiologic setting and dem- the sorting of integral membrane proteins into transport
onstrate its importance in delivery of this antigen- vesicles (Ohno et al., 1995). These results suggest that
presenting molecule to appropriate intracellular com- targeting of CD1b to MIICs and other endosomal loca-
partments. tions could be partially or completely due to the effect
of this apparent tyrosine-based targeting motif.
Introduction In the present study, mutagenesis and chimeric con-
structs have been employed to show that the tyrosine-
CD1 molecules are b2-microglobulin±associated trans- based motif is in fact both necessary and sufficient to
membrane glycoproteins that are related to major histo- direct the normal trafficking of CD1b. Furthermore,
compatibility complex (MHC)-encoded antigen-present- we show that the tyrosine-based motif is critical for
ing molecules in both structure and evolution (Porcelli, efficient presentation of M. tuberculosis antigens by
1995). The human CD1 locus on chromosome 1 contains either exogenous antigen-pulsed or M. tuberculosis±
a family of five nonpolymorphic CD1 genes, fourof which infected monocytes. These resultsdemonstrate the criti-
are known to encode expressed proteins. Three closely cal role of the tyrosine-based motif in the endosomal
related human CD1 proteins, designated CD1a, CD1b, targeting of CD1b and link the intracellular trafficking
and CD1c, are prominently expressed on specialized properties of this protein with its function in the pre-
antigen- presenting cells in a wide variety of lymphoid sentation of lipid and glycolipid antigens. Our findings
and nonlymphoid tissues.All three of these CD1 proteins also establish that an antigen-presenting molecule can
be regulated in its delivery to various compartments
within the cell by the system of adapter±protein com-# To whom correspondenceshould beaddressed (e-mail: sporcelli@
rics.bwh.harvard.edu). plexes.
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Figure 1. Localization of CD1b.WT and CD1b.
TD by Immuno-Electron Microscopy in Trans-
fected THP-1 Monocytoid Cells
(A) Labeling for CD1b.WT (10 nm gold parti-
cles) was seen in MIIC (*) and on the plasma
membrane (p). Mitochondria (m) are not la-
beled with gold. THP-1 cells have large num-
bers of microvilli resulting in the finger-like
projections and invaginations of the plasma
membrane. Scale bars, 200 nm.
(B and C) Colocalization of CD1b.WT (10 nm
gold particles and arrows) with Lamp-1 (15
nm gold particles and arrowheads) is shown
in MIIC (*). Strong labeling of CD1b.WT is seen
in early endosomes (e) without Lamp-1 label-
ing. No labeling is seen on the endoplasmic
reticulum (er) or on mitochondria (m).
(D) CD1b.TD labeling (10 nm gold particles)
is much stronger at the plasma membrane (p)
than in MIIC compartments (*).
(E) Quantitative EM was used to compare en-
dosomal density (en) of CD1b.WT to CD1b.TD
in these cells (gold particles/area, arbitrary
units 6 1 standard deviation). Plasma mem-
brane density (p) was also compared (gold
particles/length, arbitrary units). The ratios of
endosomal labeling to plasma membrane la-
beling (en/p) were then compared, showing
a 15-fold decrease for CD1b.TD as compared
to CD1b.WT.
Results within the endocytic system of transfected HeLa cells
(Sugita et al., 1996). CD1b is expressed in extrathymic
tissues mainly by dendritic cell populations and cyto-Cytoplasmic Tail±Mediated Endosomal Localization
of CD1b in Monocytic Cells kine-differentiated monocytes. Because HeLa cells are
representative of a cell lineage that does not normallyPrevious studies show that the cytoplasmic tail of CD1b
is required for the prominent localization of this protein express CD1b (i.e., epithelial origin), we extended the
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Table 1. Cytoplasmic Domains of Cd1b Mutants, Endosomal
Markers, and Other CD1 Family Members
Cytoplasmic Domain
Protein 307 311 315
CD1b.WT RRRSYQNIP*
CD1b.TD RR*
CD1b.Y311A RRRSAQNIP*
Lamp-1 RRKKSHAGYQTI*
HLA-DMb SWRRAGHSSYTPLPGSNYSEGWHIS*
CD1a RKRCFC*
CD1c KKHCSYQDIL*
CD1d KRQTSYQGVL*
Amino acid sequences are indicated by standard single letter code,
and the numbering above CD1b.WT corresponds to the residue
number of the wild-type protein. The YXXé targeting motif is under-
lined in each protein in which it is present, and the carboxy terminus
is designated with an asterisk in each case. Alanine substitution for
a wild-type residue is shown in bold.
analysis of the targeting effect of the cytoplasmic tail
sequence to the non±CD1-expressing monocytic cell
line THP-1 (Tsuchiya et al., 1980), which more closely
approximates cell types that naturally express CD1b.
Analysis of stably transfected THP-1 lines expressing Figure 2. Immunofluorescence Microscopy of CD1b Mutants
the wild-type CD1b protein (CD1b.WT) or a tail-deleted
HeLa cells stably expressing the wild-type (A) or the TD (B) or Y311A
form of this protein (CD1b.TD) was initially carried out by (C) mutant forms of CD1b were grown on cover slips, fixed with
immunofluorescence microscopy. This showed punctate paraformaldehyde, and permeabilized with digitonin. Double label-
ing for CD1b and Lamp-1 was carried out using 4A7.6 mouse anti-intracellular staining for CD1b.WT and strong surface
CD1b monoclonal antibody (detected with CY3-conjugated goatlocalization for CD1b.TD (data not shown), indicating
anti-mouse Ig [left]) and 931B rabbit anti-human Lamp-1 antiserumthat the full-length form was required for endosomal
(detected with FITC-conjugated goat anti-rabbit IgG [right]). Scalelocalization in the monocytic cell line. This effect of the
bar, 10 mm (all panels).
CD1b tail deletion on localization in THP-1 cells was
confirmed and assessed at a greater level of resolution
using immunogold labeling and electron microscopy (EM) plasma membrane CD1b labeling for CD1b.WT was 15-
fold greater than for thecytoplasmic tail deletion mutant.of ultrathin cryosections. THP-1 cells that expressed
CD1b.WT had the most prominent labeling in MIICs These results confirmed the importance of the cyto-
plasmic tail sequence for efficient endosomal targeting(which represent conventional late endocytic compart-
ments including lysosomes [Kleijmeer et al., 1997]), with of CD1b in a cell type belonging to a lineage that nor-
mally expresses this protein in vivo.detectable but low surface staining and occasional la-
beling of electron lucent early endosomes (Figure 1A).
Double-labeling with antibody to CD1b and lysosome- Critical Role of the Cytoplasmic Tyrosine Residue
for Endosomal Delivery of CD1bassociated membrane protein-1 (Lamp-1), a marker of
late endosomes and lysosomes,showed extensive colo- Because the cytoplasmic tail of CD1b contains a YXXé
motif and only five additional amino acids, it appearedcalization of these two proteins in electron-dense multi-
vesicular or multilamellar endosomes (Figures 1B and likely that the lack of this motif was responsible for the
redistribution of CD1b.TD to the plasma membrane. We1C). As measured by quantitative EM analysis (Figure
1E), endosomal labeling was significantly higher than further analyzed the molecular signal that directs CD1b
localization by comparing the localization of CD1b.WTplasma membrane labeling. Thus the distribution of
CD1b.WT in transfected THP-1 cells was similar to the and CD1b.TD with that of a mutated form of CD1b in
which the tyrosine residue of the YXXé motif at positiondistribution in monocytes that had been induced by cy-
tokine treatment to express CD1b (Sugita et al., 1996; 311 (Y311) was replaced by an alanine (CD1b.Y311A)
(Table 1).Prigozy et al., 1997).
In contrast to the pattern observed in THP-1 cells In both monocytoid cells and transfected HeLa cells,
CD1b normally colocalizes with the late endosomalexpressing CD1b.WT, immunogold labeling of CD1b in
THP-1 cells expressing CD1b.TD showed prominent ex- marker Lamp-1 (Figures 1B and 1C) (Sugita et al., 1996),
which also depends upon a YXXé motif for its correctpression on theplasma membrane with very low labeling
in either early or late endosomes (Figure 1D). In marked intracellular localization (Table 1). This colocalization
was confirmed for CD1b.WT by immunofluorescencecontrast to the result with CD1b.WT, quantitation of the
immunogold labeling of THP-1 cells transfected with microscopy of transfected HeLa cells (Figure 2A). In
contrast, colocalization with Lamp-1 was completelyCD1b.TD showed that plasmamembrane CD1b-specific
labeling was significantly higher than endosomal label- abolished either by deletion of the entire YXXé motif
in CD1b.TD (Figure 2B) or by modification of the onlying (Figure 1E). Thus, the overall ratio of endosomal to
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Figure 3. Confocal Microscopy Comparing CD1b.WT to Targeting Motif Mutants
HeLa cells stably expressing the indicated forms of CD1b were grown on cover slips and processed for immunofluorescence microscopy
after 48 hr in culture. Cells were double-labeled with 4A7.6 (CD1b, green vesicles) (detected with FITC-conjugated goat anti-mouse Ig) and
with rabbit antiserum to human Lamp-1 (red vesicles) (detected with Texas Red-conjugated goat anti-rabbit IgG). Fluorescent confocal images
were obtained for CD1b expression (green; A, D, and G) and Lamp-1 expression (red; B, E, and H). The two images were then superimposed
(C, F, and I) to show vesicles expressing both CD1b and Lamp-1 (yellow) as well as vesicles expressing only CD1b (green) or Lamp-1 (red).
Enlargements of the boxed areas in C, F, and I are shown in C9, F9, and I9. Scale bars, 10 mm and 5 mm in enlargements.
tyrosine residue within the motif in CD1b.Y311A (Figure number of Lamp-1±positive vesicles without CD1b
coexpression (Figures 3F and 3I; red vesicles). Coex-2C). This loss of endosomal localization was associated
with the acquisition of strong CD1b-specific surface pression of these forms of CD1b with Lamp-1 was lim-
ited mainly to a relatively few perinuclear vesicles thatstaining for both CD1b.TD and CD1b.Y311A, presum-
ably as a result of the mis-sorting of CD1b from intracel- were most likely terminal lysosomes (Figures 3F and 3I;
central yellow vesicles). Similar results were obtainedlular compartments to the plasma membrane.
To better observe any residual endocytic staining ob- by both immunofluorescence microscopy and confocal
microscopy using cotransfected human leukocyte anti-scured by the extremely bright surface fluorescence of
the CD1b cytoplasmic tail mutants, fluorescent confocal gen (HLA)±DM instead of endogenous Lamp-1 as a
marker for late endosomes (data not shown). Thus, themicroscopy was used to examine optical sections of
individual cells. HeLa cells expressing either the WT, point mutation of residue Y311 to alanine appeared to
have the same effect on overall localization as deletionTD, or Y311A forms of CD1b were double-labeled with
antibodies to CD1b (Figures 3A, 3D, and 3G; green) and of the entire cytoplasmic domain.
Lamp-1 (Figures 3B, 3E, and 3H; red). CD1b.WT was
found in vesicles distributed both centrally and peripher- The Cytoplasmic Tail of CD1b Was Sufficient
for Endosomal Deliveryally throughout the cells, showing a nearly complete
intracellular colocalization with Lamp-1 (Figures 3A±3C). of a Chimeric Protein
Although the effects of deletion or mutation of the CD1bIn contrast, endosomal localization of CD1b.TD and
CD1b.Y311A was markedly reduced and instead showed cytoplasmic tail demonstrated its necessary role for
endosomal localization, it remained possible that se-a marked increase in staining on the plasma membrane
(Figures 3D and 3G). Colocalization of CD1b.TD and quences within other portions of the protein also con-
tributed to this localization. Thus, to show that the cyto-CD1b.Y311A with Lamp-1 was virtually abolished in the
peripherally distributed vesicles as shown by the large plasmic domain of CD1b was sufficient in itself to control
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Figure 4. Localization of a Chimeric Protein
with a CD1b Cytoplasmic Tail
HeLa cells stably expressing HLA-B27 (top)
or B27/CYT.b (bottom) were transiently
transfected with CD1b.WT and grown on
cover slips for 48 hr, then fixed with paraform-
aldehyde and permeabilized with digitonin.
Double-labeling was carried out with anti-
HLA±B27 mAb ME-1 (mouse IgG1, detected
with tetramethylrhodamine isothiocyanate-
conjugated goat anti-mouse IgG1±specific
antibody [left]) and anti-CD1b mAb 4A7.6
(mouse IgG2a, detected with FITC-conjugated
goat F(ab9)2 anti-mouse IgG2a-specific anti-
body [right]). Both detecting antibodies had
minimal cross reactivity, as indicated by con-
trol samples stained with ME-1 or with 4A7.6
alone (data not shown).
the observed CD1b steady-state localization, a chimeric staining of B27/CYT.b but did not affect levels of
CD1b.WT (data not shown). Such differential proteaseprotein (B27/CYT.b) composed of the extracellular and
transmembrane domains of the MHC class I molecule susceptibility of these molecules is to be expected,
since the luminal portion of HLA-B27 does not normallyHLA-B27 fused to the nine amino acids of the cyto-
plasmic domain of CD1b was analyzed. As for all MHC traffic to the late endosome and presumably has not
evolved protease resistance. In contrast to the high sur-class I molecules, HLA-B27 that has passed through the
biosynthetic pathway localizes predominantly at the cell face expression of wild-type HLA-B27, the surface levels
of B27/CYT.b were low when measured by flow cytome-surface and is not normally found in endosomes to any
significant degree (Peters et al., 1991b). Effects of the try despite the strong intracellular staining seen by im-
munofluorescence microscopy. Even in the presence ofCD1b cytoplasmic tail could therefore be monitored in-
dependently of the CD1b transmembrane and extracel- leupeptin, the level of ME-1 surface staining of B27/
CYT.b transfectants remained only about 15% of thatlular domains by examining the localization of the HLA-
B27 extracellular domain in cells expressing the B27/ of wild-type HLA-B27, consistent with the profound re-
tention of the chimeric protein in intracellular compart-CYT.b chimera.
HeLa cells, which express several class I proteins ments. Thus, the patterns of localization of wild-type
HLA-B27 and the B27/CYT.b chimera could be directlynormally but do not posses the HLA-B27 allele, were
stably transfected with either the wild-type HLA-B27 correlated with the cytoplasmic tail sequences of the
expressed proteins (i.e. the amino acid sequences be-construct or the chimeric B27/CYT.b construct. Subse-
quently, the CD1b.WT construct was transiently intro- low the images in Figure 4). These results prove that the
short CD1b cytoplasmic tail was sufficient to redirect aduced into these cells to serve as a marker for wild-
type CD1b localization. Both wild-type HLA-B27 and the normally nonendosomal protein to a pattern of localiza-
tion indistinguishable from that of wild-type CD1b.B27/CYT.b chimera were detected by immunofluores-
cence with monoclonal antibody (mAb) ME-1, which
specifically recognizes an epitope present on the extra- Enhancement of Exogenous Antigen Presentation
by Endosomal Targeting of CD1bcellular domains of HLA-B27. ME-1 staining of the wild-
type HLA-B27 transfectants was seen primarily on the B lymphoblastoid cell lines (BLCL) are known to be ef-
ficient at presenting exogenously acquired antigens viacell surface, with little or no intracellular punctate stain-
ing (Figure 4, top left), and there was virtually no intracel- the MHC class II pathway, and previous studies have
shown that CD1b-transfected BLCLs can present exo-lular colocalization with the wild-type CD1b protein (Fig-
ure 4, top right). In contrast, the localization of the genous lipid antigens to CD1b-restricted T cells (Porcelli
et al., 1992; Behar et al., 1995). Therefore, BLCLs trans-chimeric B27/CYT.b molecule (Figure 4, bottom left,
again detected with ME-1) was indistinguishable from fected with wild-type or mutant forms of CD1b were
used as a model system to assess the effects of cyto-that of wild-type CD1b (Figure 4, bottom right).
Addition of protease inhibitors such as leupeptin sig- plasmic tail-mediated endosomal targeting on antigen
presentation.nificantly increased intracellular and plasma membrane
Immunity
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Stable transfectant clones of the BLCL C1R express-
ing either CD1b.WT, CD1b.TD, or CD1b.Y311A were
compared for their ability to present exogenous bac-
terial lipid and glycolipid antigens to theCD1b-restricted
T cell lines DN1 and LDN5. This was assessed by stim-
ulation of interferon g (IFNg) and granulocyte±macro-
phage colony-stimulating factor (GM-CSF) release. LDN5,
which isspecific for themycobacterial glycolipid antigen
glucose monomycolate (Moody et al., 1997), responded
in the presence of C1R cells expressing CD1b.WT at an
antigen concentration 100-fold lower than the amount
required to stimulate an equivalent response using C1R
cells expressing either CD1b.TD or CD1b.Y311A (Figure
5A). A similar result was obtained with T cell line DN1,
specific for the mycobacterial lipid antigen mycolic acid
(Porcelli et al., 1992; Beckman et al., 1994), for which
the TD and Y311A forms of CD1b also had a significantly
reduced ability to present antigen as compared to
CD1b.WT (Figure 5B). The reduced ability of CD1b.TD
and CD1b.Y311A to present antigen to LDN5 and DN1
was demonstrated consistently despite the significantly
higher surface expression of both mutant forms of CD1b
as compared with CD1b.WT in the C1R transfectants
(Figure 5C).
To demonstrate that the greater efficiency of CD1b.WT
in exogenous antigen presentation was not due to a
higher total cellular content of CD1b, quantitation was
done by Western blot analysis of immunoprecipitable
CD1b (Figure 5D). This revealed that the C1R CD1b.WT
transfectant had up to 6-fold less total immunoprecipita-
ble CD1b compared with CD1b.TD and CD1b. Y311A
transfectants, despite presenting exogenous antigen up
to 100-fold more efficiently. In addition, a panel of ten
different conformation-sensitive anti-CD1b monoclonal
antibodies showed identical patterns of reactivity with
CD1b.WT and CD1b.TD transfectants, indicating that
gross conformational differences were unlikely to be
present (data not shown). This possibility was assessed
more stringently by examining the responses of a CD1b-
reactive, foreign antigen±independent T cell line. Previ-
ous studies have described such directly reactive or
antigen-independent T cell lines that recognize target
Figure 5. Reduced Efficiency of Exogenous Antigen Presentation cells expressing CD1a, CD1c, or CD1d without a require-
by CD1b Endosomal Targeting Mutants ment for a cognate foreign antigen (Porcelli et al., 1992;
(A) LDN5 T cells specific for GMM were coincubated with C1R cells Beckman et al., 1996; Exley et al., 1997). Recently, we
expressing CD1b wild-type, mutants, or mock-transfected controls isolated a CD81 TCRab1 T cell line designated CD8.3
at various antigen doses for 48 hr, at which time the supernatants
that shows such antigen-independent direct reactivitywere harvested and levels of IFNg and GM-CSF determined by
to CD1b (D.B. Moody, R.M. Jackman and S.A. Porcelli,ELISA. Background cytokine release in the absence of antigen was
unpublished data), thus providing a useful tool withbelow detection limits. Experiments were done intriplicate with error
bars showing 61 standard deviation. which to assess the presence of native CD1b protein
(B) Same as (A) except responses of mycolic acid specific DN1 T on the surface of antigen-presenting cells (APCs) while
cells are shown. Because of low-level autoreactivity in DN1, cytokine also verifying the integrity of general APC functions.
secreted in the absence of antigen in response to each APC was
subtracted from the values shown (less than 1.3 ng/ml for IFNg and
1.0 ng/ml for GM-CSF).
(C) C1R clones used above were stained for flow cytometry with
anti-CD1b mAb BCD1b3.1 followed by FITC-conjugated goat F(ab9)2 dase±conjugated protein A and enhanced chemiluminescence for
anti-mouse Ig and analyzed by flow cytometry. Mean fluorescence detection. Differences in band intensity are quantified below each
intensity (MFI) corresponding to surface expression, is shown. lane on a relative scale by densitometry. As a control, class II a
(D) The same C1R clones were analyzed for total immunoprecipita- chain concentration was determined in parallel using L243 for immu-
ble CD1b by Western blotting. The cells were lysed and immunopre- noprecipitation and rabbit anti-human class II a antiserum for de-
cipitations for CD1bwere done using the 4A7.6 antibody. The protein tection.
was then deglycosylated and run on an SDS-PAGE gel, transferred (E) CD1b directly reactive T cell line CD8.3 was coincubated with
to a polyvinylidene difluoride membrane, and immunoblotted with an equal number of the same C1R clones expressing the CD1b
rabbit anti-human CD1b antiserum followed by horseradish peroxi- forms shown. IFNg release was determined after 48 hr of culture.
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Indeed, CD8.3 responded more strongly to C1R cells
expressing each of the mutant forms of CD1b than to
C1R cells expressing CD1b.WT (Figure 5E). Taken to-
gether, these results strongly support the hypothesis
that the reduction in exogenous antigen presentation
by APCs expressing the CD1b mutants was a direct
consequence of the alteration in their intracellular traf-
ficking and likely reflected reduced antigen loading of
CD1b in intracellular compartments.
Effects of Endosomal Targeting of CD1b
on Presentation of Antigens from Live
Intracellular Mycobacteria
In infected tissues in vivo, mycobacterial pathogens are
found predominantly intracellularly, in the vacuoles of
monocyte-derived cells. We therefore sought to eluci-
date the importance of intracellular localization of CD1b
on presentation of antigens derived from live bacteria
growing within APCs. Four independent CD1b-restricted
M. tuberculosis antigen-specific T cell lines were tested
for recognition of THP-1 promonocytic cells expressing
the wild-type or tail-deleted forms of CD1b and infected
with live virulent M. tuberculosis (strain H37Rv). Recog-
nition of the infected cells by each T cell line was mea-
Figure 6. Reduced Efficiency of Endogenously Derived Antigen Pre-sured by specific induction of cytokine secretion.
sentation by Tail-Deleted CD1bAlthough each T cell line released different absolute
(A) THP-1 cells transfected with CD1b.WT (crosshatched bars),levels of IFNg, in every case infected THP-1 cells ex-
CD1b.TD (filled bars), or untransfected THP-1 cells were infectedpressing the CD1b.WT molecule presented endoge-
with M. tuberculosis (strain H37Rv), washed, and coincubated withnously derived mycobacterial antigen significantly bet-
an equal number of the indicated T cell lines. The supernatant was
ter (Figure 6A) than those expressing CD1b.TD (Figure harvested after 22±30 hr, followed by cytokine ELISA. Nonspecific
6A). The presentation of antigen by CD1b.TD was re- IFNg secretion by T cells in response to uninfected APCs was sub-
duced despite its surface expression at a level approxi- tracted from values shown.
(B) CD8.3 cells were coincubated with uninfected THP-1 cells thatmately five times higher than that of CD1b.WT. To show
were either untransfected, positive for CD1b.WT (crosshatched bar),again that the reduced presentation by CD1b.TD was
or CD1b.TD (filled bar). Supernatants were harvested after 48 hr,most likely due to defective antigen loading of CD1b,
and the IFNg response to the untransfected THP-1 (1.76 ng/ml) was
cytokine responses of the antigen-independent CD1b- subtracted as background.
reactive T cell line CD8.3 to uninfected THP-1 cells ex-
pressing CD1b.WT or CD1b.TD were measured. In con-
trast to the results obtained with the mycobacterial anti-
gen-specific T cell lines, CD8.3 responded better to to the cell surface through the default secretory path-
THP-1 cells expressing CD1b.TD (Figure 6B), consistent way, and from MIICs that are targeted to the endocytic
with its antigen-independent recognition. Thus, for the system primarily by the modified dileucine motif present
presentation of exogenous bacterial antigens, the effi- in associated invariant chain molecules (Bakke and Dob-
cient presentation by CD1b of antigens originating from berstein, 1990; Neefjes and Ploegh, 1992).
live bacteria growing within an APC was also critically In thisstudy we demonstrate that despite theapparent
dependent on the correct intracellular trafficking of this structural similarity of CD1b to MHC class I molecules
protein. (which are loaded with peptide antigens predominantly
in the endoplasmic reticulum), the ability of CD1b to
present antigen efficiently is critically dependent on itsDiscussion
endosomal class II±like distribution. In fact, CD1b largely
lost its ability to present antigen when itassumed a moreA variety of recent studies support the view that CD1 is
a third distinct family of antigen-presenting molecules class I±like surface distribution as a result of deletion or
mutation of its targeting signal. Furthermore, our resultsfor specific T cell responses (reviewed by Porcelli, 1995;
Melian et al., 1996; Sugita et al., 1998). CD1b has unique showed that efficient recognition of M. tuberculosis±
infected monocytoid cells by CD1b-restricted T cellsintracellular trafficking properties that are distinct from
those of other known antigen-presenting molecules. was dependent on correct targeting of CD1b to the late
endosome/MIIC. All of these findings are likely to beThus, while CD1b shows strong localization to a variety
of endocytic compartments in a pattern that substan- relevant to the normal biology of this antigen-presenting
pathway.tially overlaps that of MIICs, its intracellular trafficking
and steady-state distribution is controlled by signals Previous studies in mice have shown that both MHC
class II±restricted T cells and b2m±dependent T cellspresent in its own short cytoplasmic tail. This distin-
guishes it from MHC class Imolecules that traffic directly (i.e., presumably MHC class I-restricted) participate in
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host defense to M. tuberculosis (Kaufmann, 1993). How- substantially lower surface expression. Although the al-
tered localization of this reporter molecule was apparentever, after entering macrophages, mycobacteria can se-
quester themselves in phagolysosomes and alter the without protease inhibitors, addition of leupeptin signifi-
cantly increased intracellular staining of B27/CYT.bnormal trafficking and maturation of these compart-
ments (Clemens and Horwitz, 1995). Phagolysosomes while having little effect on wild-type CD1b. This sug-
gests that CD1b has evolved protease resistance tocontaining pathogenic mycobacteria have been shown
to become depleted of the vesicular proton-ATPase, allow its traffic through the endocytic and lysosomal
vesicles, whereas the class I luminal domain does notresulting in a failure of these compartments to acidify
normally (Xu et al., 1994). These effects of mycobacterial normally traffic through these vesicles and has presum-
ably no need for protease resistance.infection may have profound negative consequences on
the presentation of mycobacterial protein antigens to CD1b is the first antigen-presenting molecule that has
been shown to be dependent on a YXXé motif for itsMHC-restricted T cells. Indeed, monocyte-derived mac-
rophages that are chronically infected with M. tubercu- localization. HLA-DM, a molecule that facilitates peptide
loading of MHC class II molecules, also uses such alosis have been shown to become ineffective at stimu-
lating CD41 MHC class II±restricted T cells in vitro motif for its localization (Table 1 and Marks et al., 1995).
This is significant considering the demonstrated colo-(Pancholi et al., 1993). Presentation of lipid antigens by
the CD1 system in infected cells may help to overcome calization of MHC class II, HLA-DM, and CD1b in MIIC.
Compared to other late endosomal/lysosomal targetedthis putative defect, since mycobacterial lipids such as
LAM have been shown to traffic actively out of the M. proteins that contain such a targeting motif and are
found almost exclusively intracellularly, the endosomaltuberculosis phagosome and become widely dispersed
throughout the endocytic system and on the plasma targeting motif of CD1b appears to be relatively weak
and thus allows a higher proportion of CD1b to remainmembrane of infected cells (Xu et al., 1994). Thus, CD1b
could allow T cell recognition of infected macrophages on the cell surface. A YXXé motif is predicted to induce
a ªtight turnº structure (Bansal and Gierasch, 1991;in situations in which MHC class II function is severely
impaired or effectively eliminated. Eberle et al., 1991) that associates with adapter com-
plexes and allows clathrin-mediated internalization. TheA mechanism for the cotargeting of relevant glycolipid
antigens into the MIIC was recently demonstrated (Pri- identity of the Y11 and Y12 amino acids in a YXXé
motif can influence the strengthof its interaction with thegozy et al., 1997). Previous studies have also shown that
treatment of CD1b1 APCs with inhibitors of endosomal AP-2 adapter complex (which mediates internalization
from the plasma membrane). This interaction has beenacidification or fixation of the APCs prior to antigen
pulsing completely blocks presentation of lipid antigens reported to be strongest when both of these are polar
residues (Boll et al., 1996). CD1b contains asparagineto CD1b-specific T cells (Porcelli et al., 1992; Sieling et
al., 1995). Together these findings suggest that lipid and isoleucine at these positions, predicting a relatively
lower affinity for AP-2 and therefore a relatively slowantigen loading of CD1b occurs in an acidic intracellular
compartment. This is consistent with our findings that internalization from the plasma membrane.
In Lamp-1, the spacing of the YXXé motif relative toa major intracellular site of CD1b accumulation is the
MIIC, and that failure to target to this internal low-pH the membrane has also been shown to be critical for
effective endocytic targeting. Placing the motif a singlecompartment (due to lack of a proper targeting se-
quence) abolishes antigen-dependent recognition by T amino acid closer to the membrane significantly re-
duced the rate of internalization from the plasma mem-cells.
Our EM findings showed that the cytoplasmic tail of brane, whereas extending the distance from the mem-
brane increased internalization (Rohrer et al., 1996),CD1b was critical for its localization to the late endoso-
mal/MIIC compartments ina physiologically relevant cell presumably because of changes in the relative accessi-
bility to the AP-1 and AP-2 adapter complexes. In CD1btype. In the absence of the cytoplasmic tail, CD1b was
concentrated on the monocyte cell surface with rela- the tyrosine-based motif is very close to the membrane,
two amino acids closer than in Lamp-1. A CD1b mutanttively little localized in late endosomal compartments.
These findings were extended using both immunofluo- that increases the spacing of the motif relative to the
membrane by five amino acids shows a marked increaserescence and confocal microscopy to show that this
targeting was dependent on the single tyrosine residue in endocytic localization relative to surface localization
(R. M. J., unpublished data). These data, together withfound within the YXXé motif in the cytoplasmic tail of
CD1b. Similarly, other studies have shown that mutation the prominent visualization of CD1b in clathrin-coated
vesicles (Sugita et al., 1996), suggest a recycling path-of the tyrosine in the YXXé targeting signals in mole-
cules such as Lamp-1 (Williams and Fukuda, 1990) can way whereby CD1b is serially internalized and delivered
to endosomes. As is now believed to be the case forcause the redistribution of these molecules to the cell
surface. Thus, the current studies directly confirm the MHC class II (Pinetet al., 1995), recycling may provide an
important alternative pathway for presentation of certainrole of residue Y311 and the YXXé motif in controlling
the steady-state localization of CD1b. lipid antigens. However, the relative importance of CD1b
targeting to relevant endosomal compartments via aOur results also show that the nine±amino acid cyto-
plasmic tail of CD1b is both necessary and sufficient recycling pathway versus direct targeting from the
trans±Golgi network remains to be established.to confer its wild-type localization on a nonendocytic
reporter protein, such as an MHC class I heavy chain. Although these studies focus exclusively on CD1b, it
appears likely that endosomal targeting will also proveIt is remarkable that the motif, when placed on HLA-
B27, replicates CD1b localization even to the level of important for several other CD1 proteins. Both CD1c
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anti-human CD1b antiserum (Sugita et al., 1997) also have beenand CD1d have cytoplasmic tail motifs similar to that of
previously described. Commercially available antibodies used wereCD1b (Table 1), and preliminary studies show that both
indocarbocyanine (CY3)±conjugated goat anti-mouse IgG andof these molecules also localize within the endocytic
Texas Red (TR)±conjugated goat anti-rabbit IgG (Jackson Immuno-
system (R. M. J. and S. A. P., unpublished data). How- research Laboratories, West Grove, PA); fluorescein isothiocyanate
ever, the localization of CD1c and CD1d to endosomes (FITC)±conjugated goat F(ab9)2 anti-mouse Ig and FITC±conjugated
goat F(ab9)2 anti-rabbit IgG (Biosource International, Camarillo, CA);in transfected HeLa cells appears to be less prominent
and tetramethylrhodamine isothiocyanate±conjugated goat anti-than observed for CD1b, and a larger cohort of the for-
mouse IgG1±specific antibody and FITC-conjugated goat F(ab9)2mer proteins seem to reside on the plasma membrane.
anti-mouse IgG2a±specific antibody (Southern Biotechnology Asso-The precise identity of the endocytic compartments to
ciates, Birmingham, AL).
which CD1c and CD1d are transported and the func-
tional significance of this localization remain tobe estab- Construction of CD1b Mutants and Transfections
lished. Thus, while human CD1c and murine CD1d are Construction of CD1b.WT and CD1b.TD with subcloning into pSRa-
neo has been described previously (Porcelli et al., 1989; Sugita etknown to present lipid antigens to T cells (Beckman et
al., 1996). cDNA for CD1b.Y311A was generated by polymeraseal., 1996; Kawano et al., 1997), the dependence of this
chain reaction using CD1b.WT as template DNA. Primers used werepresentation on endosomal targeting has not yet been
59-AGTGAACATGCCTTCCAGGGGCCGACC-39 and 59-TCGGGATC
shown. Interestingly, CD1a has no discernible targeting CTATGGGATATTCTGAGCTGACCGGCGCCTC-39. The amplified frag-
motif in its cytoplasmic tail (Table 1), and has been found ment was cloned and sequenced, and the EcoRI-to-BamHI region
to localize to the plasma membrane with little late endo- (39 terminus) was subcloned into similarly digested pSRaneo-
CD1b.WT to give the mutant construct.somal localization in most cell types examined (M. S. et
Construction of the HLA-B27 construct has been described (Sug-al., unpublished data). Nevertheless, this molecule has
ita and Brenner, 1995). Polymerase chain reaction was used tobeen found to present mycobacterial lipid antigens to
generate B27/CYT.b using HLA-B2705 as template. Primers used
T cells (Rosat and Brenner, submitted). Although further were 59-ATGGCTGCGACGTGGGGCC-39 (plus strand within B27)
studies are required, these preliminary findings suggest and 59-TCTAGATCATGGGATATTCTGATATGACCGCCTCCTACAC
the possibility that the individual CD1 family members ATCACAGCAGCG-39 (minus strand, cytoplasmic domain of CD1b
fused to HLA-B27 transmembrane region). The amplified fragmentmay have evolved to efficiently survey different cellular
was cloned and sequenced, and the SalI-to-XbaI region was sub-compartments and to present distinct species of lipid
cloned into the HLA-B27 construct for expression.antigens that associate with these compartments.
Electroporation was used (Gene Pulser Apparatus, Bio-Rad Labo-
In conclusion, we have shown that the cytoplasmic ratories, Hercules, CA) to introduce the plasmid expression con-
tail of CD1b is both necessary and sufficient for normal structs into suspension cells (C1R: 300 V, 960 mF; THP-1: 200 V,
targeting of CD1b, and that the mutation of a single 960 mF), and CaPO4-mediated DNA precipitation was used for HeLa
cells, followed by selection for G418 resistance and cloning.tyrosine within the tyrosine-based endocytic motif is
sufficient to abrogate this targeting. Furthermore, this
Immunofluorescence and Confocal Microscopytargeting was shown to be critical for presentation of
HeLa cells were grown for immunofluorescence on glass coverslips,both exogenous lipid and glycolipid antigens as well as
fixed with 3.7% paraformaldehyde, permeabilized with 0.1% digito-
antigens derived from live mycobacteria growing within nin, and incubated with primary and secondary antibodies in 5%
antigen-presenting cells. Together, this information im- goat serum. Cover slips were mounted for observation on glass
slides in Vectashield mounting medium (Vector Laboratories, Burl-plicates the late endosome/MIIC as the primary location
ingame, CA) as an antifading agent.for antigen loading of CD1b. Our results provide a link
For confocal microscopy, cells were fixed and labeled as de-between the intracellular trafficking properties of CD1b
scribed above and then examined using a Leica TCS-NT confocaland its probable function in the host response to persis-
laser scanning microscope fitted with krypton and argon lasers.
tent intracellular pathogens such as M. tuberculosis. Cells were illuminated with 488 and 568 nm light after filtering
through an acoustic optical device. Images of cells decorated with
FITC and Texas Red were recorded simultaneously through sepa-Experimental Procedures
rate optical detectors using a 530 6 15 nm bandpass filter and a
590 nm long pass filter, respectively. Pairs of images were superim-Cell Lines and Antibodies
posed for colocalization analysis (Rogers et al., 1993).The antigen-specific T cell lines DN1 (Porcelli et al., 1992), DN.OR
and CD8.TX (Stenger et al., 1997), and LDN5 (Moody et al., 1997)
Immunogold EMhave been described. CD8.3 was derived from human peripheral
Procedures used for EM have been described previously (Peters etblood lymphocytes selected for the CD81 phenotype. This line was
al., 1991a). Standard quantitative analysis (Liou et al., 1997) wasestablished from cultures expanded by two rounds of stimulation
performed on photographic prints of electron micrographs of 25with 2.3 mg/ml trehalose dimycolate (Sigma, St. Louis, MO) and
cells chosen at random for each cell type. Each print (12,0003,autologous, irradiated monocytes previously cultured with 300 U/ml
corresponding to approximately 38 mm2) contained plasma mem-GM-CSF and 200 U/ml IL-4 to induce CD1 expression. Subse-
brane and an area of cytoplasm. A transparent sheet of single 1 cm2quently, CD8.3 was stimulated with trehalose dimycolate and ran-
lattice grid area was superimposed on the prints, and the plasmadom donor irradiated monocytes previously stimulated with GM-
membrane and endosomal surface areas (arbitrary units) were esti-CSF and IL-4.
mated by scoring intersections with the grid. Endosomal gold parti-HeLa and THP-1 cells were obtained from the American Type
cles counted were 762 for CD1b.WT (n 5 21 photographs) andCulture Collection (ATCC, Rockville, MD). C1R cells were obtained
292 for CD1b.TD (n 5 20) on surface areas of 836 and 657 units,from Peter Cresswell (Yale University, New Haven, CT). The mouse
respectively. Similarly, the plasma membrane gold particle countmonoclonal antibodies 4A7.6 (anti-CD1b, IgG2a [Olive et al., 1984])
was 150 for CD1b.WT and 1301 for CD1b.TD on surface lengths ofand BCD1b3.1 (anti-CD1b, IgG1 [Behar et al., 1995]) have been de-
805 and 1005 units, respectively.scribed. ME-1 (anti-HLA±B27, ±B7, and ±Bw22; IgG1 [Ellis et al.,
1982]) was purified from a hybridoma obtained from the ATCC.
Rabbit anti-human Lamp-1 antiserum (Fukuda et al., 1988), rabbit Cytokine Assays
T cell activation for cytokine release was done using 1 3 105 T cells/anti-human HLA-DMb antiserum (Denzin et al., 1994), rabbit anti-
human class II a chain antiserum (Neefjes et al., 1990), and rabbit well in 96-well U-bottomed plates stimulated with an equal number
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